Drug Discovery Africa – Abstract Submission
Submissions are invited for poster sessions and short-talks at Drug Discovery Africa.
Refreshment breaks and lunch will be co-located with the posters providing plenty of opportunity to network and discuss your project with fellow attendees.
There will also be an opportunity for a few submitted abstracts to be chosen for oral presentation in the sessions alongside the invited speakers. If you would like to be considered for a speaking slot (10 min) then please indicate this on your abstract submission form.
Abstracts to be considered for a short-talk and/or if you wish to be considered for a travel bursary (available to early career researchers from Africa giving either a short-talk or poster) must be submitted by 27th October 2024.
All abstracts for oral presentation will be reviewed after this submission date. Successful applicants will be informed by 20th November 2024.
Abstracts for posters will be accepted until 16th December 2024.
There will be prizes for best poster and short-talk.
All presentations will be in English.
Important Note
If you are submitting an abstract and applying for a travel bursary please do not register until after you hear the outcome of your application . Free registration tickets will be made available to everyone offered a travel bursary.
All other presenters accepted through the abstract submission process and/or presenting at the conference must register for and pay to attend the conference, and are responsible for their own related expenses. In addition, if the accepted presenter invites additional speakers to present with them at the conference, they must also register for and pay to attend the conference.
Presenting authors should only present a single poster. Groups of authors who are able to submit multiple abstracts should ensure a different presenting author for each poster.
Writing the Abstract
To help us group posters at the conference please indicate which conference topic the subject matter of your abstract matches on the submission form. 
Choose from:
- Clinical Trials and Field Studies
- Drug Targets and Drug Validation
- Medicinal and Computational Drug Discovery
- DMPK and Toxicology
- Drug Discovery Networks
When listing Abstract authors on the submission form please do so in the following manner for each author:
First name Family Name Institution; First Name Family Name Institution; etc
e.g. John Smith University of Dundee; Jane Brown University of Ghana
The abstract submitted should not exceed 350 words.
Avoid specialized jargon and undefined abbreviations. Do not include tables, figures or diagrams in the text of the abstract.
Abstract submissions should be for research that is either complete or will have significant findings by the conference date.
Authors accept sole responsibility for the statements in their abstracts. Abstracts should be carefully proofread to avoid errors. Please note that the main body of the abstract will not be edited, thus the author is responsible for any spelling, grammatical or typographical errors. Once the abstract has been submitted, editing can only be performed in exceptional circumstances by contacting the organizers. Abstracts will be included in the conference programme.